Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer

This study is testing whether a minimally invasive (laparoscopic or robotic) hysterectomy — removal of the uterus — is a safe alternative to open surgery for women with low-risk early-stage cervical cancer. Traditional guidelines have shifted toward open surgery, but this trial seeks to define a low-risk group where less invasive surgery is still safe. **You may be eligible if...** - You are 18 or older - You have been diagnosed with cervical cancer (squamous cell, adenocarcinoma, or adenosquamous type) - Your cancer is early-stage (FIGO 2018 stage IA2–IB1) with a tumor no larger than 2 cm - The depth of cancer invasion is no more than 10mm (confirmed by cone biopsy or imaging) - You have not had prior pelvic radiotherapy **You may NOT be eligible if...** - Your tumor is larger than 2 cm - The cancer has invaded more than 10 mm deep or more than 50% of the cervical wall - You have a rare cancer type (neuroendocrine, clear cell, or serous) - You are pregnant or wish to preserve your fertility - You have had previous pelvic radiation - Your cancer has come back (recurrent cervical cancer) - More than 4 months have passed since diagnosis if your surgical margins were clear Talk to your doctor to see if this trial is right for you.